TY - JOUR
T1 - Incidence and prevalence of hyperthyroidism: a population-based study in the Piedmont Region, Italy
AU - CAPUTO, Marina
AU - Pecere, A.
AU - Sarro, A.
AU - Mele, C.
AU - Ucciero, A.
AU - Pagano, L.
AU - PRODAM, Flavia
AU - AIMARETTI, Gianluca
AU - MARZULLO, Paolo
AU - BARONE ADESI, Francesco
N1 - Publisher Copyright:
© 2020, Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2020
Y1 - 2020
N2 - Purpose: Unrecognized and untreated hyperthyroidism leads to serious clinical complications with adverse outcomes for patients and increasing costs for the health care system. Hence, adequate knowledge of the epidemiological features of such condition is desirable to plan effective interventions. The aim of our study was to estimate incidence and prevalence of hyperthyroidism in the mildly iodine-deficient Italian Region of Piedmont. Methods: A retrospective cohort study was conducted using Administrative Health Databases of the Piedmont Region, Italy (2012–2018). Hyperthyroidism cases were defined as the subjects who had at least one of the following claims: (i) hospital discharge records with hyperthyroidism diagnosis code; (ii) exemption from co-payment for hyperthyroidism; (iii) prescription of one of the following medications: methimazole, propylthiouracil, or potassium perchlorate. Results: The overall prevalence was 756 per 100,000 inhabitants [95% CI 748–764], and the overall incidence was 81 per 100,000-person year [95% CI 80–82]. The prevalence and incidence increased with age and were two-fold higher among women than men. Women also showed two distinct peaks in incidence at the age of 30 and 50; after the age of 60, the trend became similar between sexes. With regard to the geographic distribution, an increasing gradient of incidence was observed from the northern to the south-western areas of the Region. Conclusion: This is the first Italian study based on health databases to estimate the incidence and prevalence of hyperthyroidism in the general population. This approach can represent an inexpensive and simple method to monitor patterns of hyperthyroidism in iodine-deficient areas.
AB - Purpose: Unrecognized and untreated hyperthyroidism leads to serious clinical complications with adverse outcomes for patients and increasing costs for the health care system. Hence, adequate knowledge of the epidemiological features of such condition is desirable to plan effective interventions. The aim of our study was to estimate incidence and prevalence of hyperthyroidism in the mildly iodine-deficient Italian Region of Piedmont. Methods: A retrospective cohort study was conducted using Administrative Health Databases of the Piedmont Region, Italy (2012–2018). Hyperthyroidism cases were defined as the subjects who had at least one of the following claims: (i) hospital discharge records with hyperthyroidism diagnosis code; (ii) exemption from co-payment for hyperthyroidism; (iii) prescription of one of the following medications: methimazole, propylthiouracil, or potassium perchlorate. Results: The overall prevalence was 756 per 100,000 inhabitants [95% CI 748–764], and the overall incidence was 81 per 100,000-person year [95% CI 80–82]. The prevalence and incidence increased with age and were two-fold higher among women than men. Women also showed two distinct peaks in incidence at the age of 30 and 50; after the age of 60, the trend became similar between sexes. With regard to the geographic distribution, an increasing gradient of incidence was observed from the northern to the south-western areas of the Region. Conclusion: This is the first Italian study based on health databases to estimate the incidence and prevalence of hyperthyroidism in the general population. This approach can represent an inexpensive and simple method to monitor patterns of hyperthyroidism in iodine-deficient areas.
KW - Administrative Health Databases
KW - Hyperthyroidism
KW - Incidence
KW - Prevalence
KW - Administrative Health Databases
KW - Hyperthyroidism
KW - Incidence
KW - Prevalence
UR - https://iris.uniupo.it/handle/11579/111592
U2 - 10.1007/s12020-020-02222-7
DO - 10.1007/s12020-020-02222-7
M3 - Article
SN - 1355-008X
VL - 69
SP - 107
EP - 112
JO - Endocrine
JF - Endocrine
IS - 1
ER -